-The Times of India NEW DELHI: Around 40% of the essential medicines in India with lowest MRP are priced significantly higher than estimated production costs, an assessment by the World Health Organisation (WHO) shows highlighting the “exorbitant” profiteering by pharmaceutical companies and the scope for lowering prices of drugs. While innovative and newer drugs for cancer, hepatitis C and rare diseases are out of reach of many due to their unaffordable prices,...
More »SEARCH RESULT
Total Matching Records found : 172
Every drop matters -Kevin James & Shreya Shrivastava
-The Hindu The regulatory framework must be reformed to ensure access to safe and sufficient blood A ready supply of safe blood in sufficient quantities is a vital component of modern health care. In 2015-16, India was 1.1 million units short of its blood requirements. Here too, there were considerable regional disparities, with 81 districts in the country not having a blood bank at all. In 2016, a hospital in Chhattisgarh turned...
More »'Many combination drugs not approved by regulator' -Afshan Yasmeen
-The Hindu Study raises safety, efficacy concerns; call for ban of irrational formulations Of the 110 anti-TB (tuberculosis) Fixed Dose Combinations (FDCs) available in India, only 32 (less than 30%) have been approved by the Central Drugs Standard Control Organisation (CDSCO), the country’s drug regulator. In the case of malaria FDCs, only eight out of 20 (40%), have been approved. These statistics, that give rise to safety and efficacy concerns, have been brought...
More »Cure In Progress -Poonam Khetrapal Singh
-The Indian Express Deliberations at UN show resolve to address public health challenges at highest level. On September 26, the UN General Assembly (UNGA) deliberated on how best to address a serious public health challenge — tuberculosis (TB). A day later, the world’s most esteemed political forum deliberated on combating non-communicable diseases (NCDs). For several years, WHO South East Asia and its member states have been ground zero in the battle against...
More »India on radar as Trump aims for cheaper drugs?
-The Times of India and other agencies WASHINGTON: United States President Donald Trump has promised to bring the cost of prescription drugs in the country "way down" and let other countries pay more for these medicines. If effected, Trump's new policy on prescription drugs, dicussed with his cabinet at the White House on Monday, could have grave implications for India. The US has long had a grouse with India over its patent...
More »
